Febrile neutropenia and sepsis are the most common oncologic emergency. Infections are the primary cause of morbidity and mortality in patients with cancer. About 50% of patients with febrile neutropenia have a hematologic malignancy. Out of all patients who die from febrile neutropenia, 70% have a hematologic malignancy.

In this online training, Jane Li, nurse practitioner and Melissa Lo, clinical trials pharmacist in oncology-hematology, both working at Princess Margaret Center, will address:
• Physiology of febrile neutropenia
• Febrile neutropenia risks and sources
• Nursing considerations
• Investigations and management
• Pharmacological considerations
• Primary secondary prophylaxis